Monday, January 23, 2023 by: Ethan Huff
Tags: #nutrition, acetylcysteine, alternative medicine, antiviral, BromAc, Bromelain, COVID, discoveries, goodhealth, goodmedicine, goodscience, infections, natural cures, natural health, natural medicine, nutraceuticals, nutrients, outbreak, pandemic, prevention, remedies, research, spike protein, supplements
This article may contain statements that reflect the opinion of the author
22KVIEWS
(Natural News) Is it possible to mitigate the damaging effects of covid “vaccine”
spike proteins through simple nutrition? A new
study published in the
journal Viruses seems to suggest so.
Australian
researchers looked at two common nutritional supplements – bromelain and
acetylcysteine (BromAc) – that are capable of unfolding the
structures that hold spike proteins together, effectively neutralizing them.
Severe acute
respiratory syndrome coronavirus, also known as SARS-CoV-2, is demarcated by a
spike glycoprotein and envelope protein that contains disulfide bridges for
stabilization. They bind to the ACE2 receptor in host cells present in the
nasal mucosa, triggering infection.
A BromAc
treatment, the team found, is capable of “synergistic action against
glycoproteins” in that the nutritional duo breaks apart the glycosidic linkages
and disulfide bonds, reducing or even eliminating the ability of spike proteins
to cause covid infection.
These same
spike proteins, just to clarify, are present inside all of the
so-called “vaccines” currently available to the public. Some would argue that
the only source of these spike proteins is the injections, and
that covid itself does not exist since the alleged virus has never
been isolated.
“We sought to
determine the effect of BromAc on the spike and envelope proteins and its potential
to reduce infectivity in host cells,” the paper reads. “Recombinant spike and
envelope SARS-CoV-2 proteins were disrupted by BromAc. Spike and envelope
protein disulfide bonds were reduced by Acetylcysteine.”
“In in
vitro whole virus culture of both wild-type and spike mutants,
SARS-CoV-2 demonstrated a concentration-dependent inactivation from BromAc
treatment but not from single agents. Clinical testing through nasal
administration in patients with early SARS-CoV-2 infection is imminent.”
Is BromAc a natural solution for covid jab spike protein damage?
While
treatment with acetylcysteine alone did not show any alteration of spike
proteins, a combination of acetylcysteine and bromelain, or BromAc, at 50 and
100
µ
g/20 mg/mL and 50 and 100µ g/mL, respectively, resulted in significant protein
alteration.
“Treatment
with Acetylcysteine on the envelope protein did not alter the protein, whereas
treatment with Bromelain at 50 and 100µ g/mL and BromAc at 50 and 100µ g/20
mg/mL also resulted in near complete and complete fragmentation, respectively,”
the paper further explains.
In other
words, combining these two nutrients at the levels depicted in the study led to
destabilization and unraveling of covid spike proteins, which is good news for
everyone who got jabbed, as well as for those who may have had spike protein
“shed” on them from a fully vaccinated person.
Since the
tests were conducted in vitro, or in a test tube, more study is
needed to determine if the same results can be achieved in actual human subjects.
Still, the results are “encouraging,” the researchers say, pointing to a
natural solution for covid spike proteins that otherwise outsmart most other
potential remedies.
“There is
currently no suitable therapeutic treatment for early SARS-CoV-2 aimed at
preventing disease progression,” the authors note. “BromAc is under clinical
development by the authors for mucinous cancers due to its ability to alter
complex glycoprotein structures. The potential of BromAc on SARS-CoV-2 spike
and envelope proteins stabilized by disul?de bonds was examined and found to
induce the unfolding of recombinant spike and envelope proteins by reducing
disul?de stabilizer bridges.”
“BromAc also
showed an inhibitory effect on wild-type and spike mutant SARS-CoV-2 by inactivation
of its replication capacity in vitro. Hence, BromAc may be an
effective therapeutic agent for early SARS-CoV-2 infection, despite mutations,
and even have potential as a prophylactic in people at high risk of infection.”
You can read
the full story for free at ResearchGate.net.
You will also
find more stories like this at CoronavirusNutrients.com.
Sources for
this article include:
